Marc Morris, M.D./J.D.VICE PRESIDENT, PHARMACOVIGILANCE
Marc Morris is responsible for the safety risk management of Apellis products, supporting safe and informed treatment with our medicines, and fulfilling global regulatory requirements for patient safety. Marc has extensive experience with safety surveillance and risk mitigation with marketed products and drugs in development with such companies as Roche, GlaxoSmithKline and BeiGene. Dr Morris has a special interest in specialty therapies for patients with serious illnesses, including pharmaceuticals and biological products. Dr. Morris has degrees in Biochemistry and Medicine from the University of London and a Masters in Pharmaceutical Medicine from the University of Surrey. He also has a Law Degree from Temple University.